Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
A 200 ug/kg or 2 ug/kg dose of BPC 157 was intraperitoneally injected 10 minutes post-injury followed by the return of animals to their cages and assignment to interval groups varying from days 7, 15, 20, 90, 180, and 360
Occupancy stays low, but each engaged receptor keeps sending its main message longer than it would under a balanced signal (cAMP bias with low receptor internalization). In a head-to-head trial against liraglutide, tirzepatide reduced measured food intake and craving more despite lower GLP-1 occupancy. The effect lowers the drive to eat rather than increasing restraint
What are the benefits of BPC 157
The abdomen (at least two inches from the navel) is most common
AHK-Cu's copper-peptide structure gives it some advantage over larger molecules: peptides in the tripeptide size range are generally considered more permeable than larger protein fragments
However, differences in absorption, safety, and effectiveness are not well established in large human trials
